XML 42 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity (Tables)
6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Equity
 
  
Common Stock
Other
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
 
Treasury Stock
Non-
Controlling
Interests
Total
($ and shares in millions)
Shares
Par Value
Shares
Cost
Balance at January 1, 2017
3,577

$
1,788

$
39,939

$
44,133

$
(5,226
)
828

$
(40,546
)
$
220

$
40,308

Net income attributable to Merck & Co., Inc.



3,496





3,496

Other comprehensive income, net of taxes




132




132

Cash dividends declared on common stock



(2,583
)




(2,583
)
Treasury stock shares purchased





34

(2,153
)

(2,153
)
Share-based compensation plans and other


(163
)


(12
)
646


483

Acquisition of Vallée







25

25

Net income attributable to noncontrolling interests







11

11

Other changes in noncontrolling ownership interests







(7
)
(7
)
Balance at June 30, 2017
3,577

$
1,788

$
39,776

$
45,046

$
(5,094
)
850

$
(42,053
)
$
249

$
39,712

Balance at January 1, 2018
3,577

$
1,788

$
39,902

$
41,350

$
(4,910
)
880

$
(43,794
)
$
233

$
34,569

Adoption of new accounting standards (see Note 1)



322

(274
)



48

Net income attributable to Merck & Co., Inc.



2,443





2,443

Other comprehensive income, net of taxes




62




62

Cash dividends declared on common stock



(2,592
)




(2,592
)
Treasury stock shares purchased





37

(2,162
)

(2,162
)
Share-based compensation plans and other


(161
)


(10
)
555


394

Net income attributable to noncontrolling interests







14

14

Distributions attributable to noncontrolling interests







(10
)
(10
)
Balance at June 30, 2018
3,577

$
1,788

$
39,741

$
41,523

$
(5,122
)
907

$
(45,401
)
$
237

$
32,766